ArticleScience translational medicine2019

A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.

Lena F Burbulla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.